BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 23604100)

  • 41. Hemolytic anemia in patients receiving daily dapsone for the treatment of leprosy.
    Deps P; Guerra P; Nasser S; Simon M
    Lepr Rev; 2012 Sep; 83(3):305-7. PubMed ID: 23356031
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Amino Acid Variants of HLA-DRB1 Confer Susceptibility to Dapsone Hypersensitivity Syndrome in Addition to HLA-B*13:01.
    Yue Z; Sun Y; Wang C; Yu W; Cao J; Bao F; Wang Z; Liu H; Zhang F
    J Invest Dermatol; 2018 May; 138(5):1101-1106. PubMed ID: 29233746
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dapsone induced pulmonary eosinophilia without cutaneous allergic manifestations--an unusual encounter--a case report.
    Arunthathi S; Raju S
    Acta Leprol; 1998; 11(1):3-5. PubMed ID: 9693685
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Vitamin E as protective agent against hemolysis in leprosy patients under dapsone treatment].
    Lardo MM; Díaz NB; Artaza JR; Carbia CD; Nazer R; Valdez R
    Medicina (B Aires); 1997; 57(2):150-4. PubMed ID: 9532824
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Causes of death among active leprosy patients in China.
    Shen J; Liu M; Zhou M; Li W
    Int J Dermatol; 2011 Jan; 50(1):57-60. PubMed ID: 21182503
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Anatopic response: Double sparing phenomenon in a patient with dapsone hypersensitivity syndrome.
    Maddala RR; Ghorpade A; Adulkar S; Polavarapu M
    Indian J Dermatol Venereol Leprol; 2017; 83(2):241-243. PubMed ID: 27852986
    [No Abstract]   [Full Text] [Related]  

  • 47. T-cell plasticity of dapsone and DRESS.
    Markova A; Duquesnoy R; Levis W
    J Drugs Dermatol; 2014 Jan; 13(1):12-3. PubMed ID: 24385113
    [No Abstract]   [Full Text] [Related]  

  • 48. The management of leprosy.
    Boughton CR; Lloyd AR
    Med J Aust; 1987 Jun; 146(11):593-9. PubMed ID: 3302636
    [No Abstract]   [Full Text] [Related]  

  • 49. Dapsone syndrome occurring in two brothers.
    Jamrozik K
    Lepr Rev; 1986 Mar; 57(1):57-62. PubMed ID: 3702581
    [No Abstract]   [Full Text] [Related]  

  • 50. Adverse effects of multi-drug therapy in leprosy, a two years' experience (2006-2008) in tertiary health care centre in the tribal region of Chhattisgarh State (Bastar, Jagdalpur).
    Singh H; Nel B; Dey V; Tiwari P; Dulhani N
    Lepr Rev; 2011 Mar; 82(1):17-24. PubMed ID: 21644468
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hepatic and haematological adverse reactions associated with the use of multidrug therapy in leprosy--a five year retrospective study.
    Kaluarachchi SI; Fernandopulle BM; Gunawardane BP
    Indian J Lepr; 2001; 73(2):121-9. PubMed ID: 11579648
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dapsone Hypersensitivity Syndrome (DHS): A Detrimental Effect of Dapsone? A Case Report.
    Shukkoor AA; Thangavelu S; George NE; Priya S
    Curr Drug Saf; 2019; 14(1):37-39. PubMed ID: 30062974
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Drugs used in tuberculosis and leprosy].
    Aoyagi T; Toyoda T
    Nihon Rinsho; 1990 Oct; 48(10):2212-7. PubMed ID: 2280466
    [No Abstract]   [Full Text] [Related]  

  • 54. Hypersensitivity reactions to dapsone: a systematic review.
    Lorenz M; Wozel G; Schmitt J
    Acta Derm Venereol; 2012 Mar; 92(2):194-9. PubMed ID: 22307940
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Overview and Current Advances in Dapsone Hypersensitivity Syndrome.
    Wang ZZ; Zeng R; Wu ZW; Wang C; Jiang HQ; Wang HS
    Curr Allergy Asthma Rep; 2023 Nov; 23(11):635-645. PubMed ID: 37804376
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Short-term multidrug therapy in multibacillary leprosy--review of 80 cases in two provinces of China (1983-1988).
    Li HY; Yu XL; Zhang MS; Duan CX; Huang WB; Zhang SB; Zhu K; Ma JF
    Int J Lepr Other Mycobact Dis; 1989 Sep; 57(3):622-7. PubMed ID: 2778368
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dapsone-induced motor polyneuropathy in a patient with leprosy.
    Pavithran K; Satish TC
    Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):262-3. PubMed ID: 9251603
    [No Abstract]   [Full Text] [Related]  

  • 58. Antileprosy drugs, pregnancy and fetal outcome.
    Bhargava P; Kuldeep CM; Mathur NK
    Int J Lepr Other Mycobact Dis; 1996 Dec; 64(4):457-8. PubMed ID: 9030117
    [No Abstract]   [Full Text] [Related]  

  • 59. Dapsone hypersensitivity syndrome complicated by Scedosporium apiospermum pneumonia in an immunocompetent patient.
    Ceccarelli L; Calisti G; Delle Rose D; Ricciardi A; Maffongelli G; Sordillo P; Sarmati L; Andreoni M
    Infection; 2012 Aug; 40(4):459-62. PubMed ID: 22124953
    [No Abstract]   [Full Text] [Related]  

  • 60. A case of linear immunoglobulin A disease with dapsone hypersensitivity and its management strategies.
    Verma R; Vasudevan B; Sagar A; Pragasam V; Deb P; Choden G
    Indian J Dermatol Venereol Leprol; 2013; 79(6):833-5. PubMed ID: 24177627
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.